Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

SYNALGOS-DC-A

ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE

Standard Dose
356.4MG;30MG;16MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview SYNALGOS-DC-A is listed in Drugs@FDA under application 089166 (ANDA).

Marketing status: Discontinued Active ingredient ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE Form and strength CAPSULE;ORAL - 356.4MG;30MG;16MG Sponsor LEITNER PHARMS Submission history Latest submission status date: 1986-10-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview SYNALGOS-DC-A is listed in Drugs@FDA under application 089166 (ANDA). Marketing status: Discontinued Active ingredient ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE Form and strength CAPSULE;ORAL - 356.4MG;30MG;16MG Sponsor LEITNER PHARMS Submission history Latest submission status date: 1986-10-27 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.